Treatment News : HIV Meds Greatly Benefit South Africans, But Favor Women

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » March 2014

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


March 13, 2014

HIV Meds Greatly Benefit South Africans, But Favor Women

CROI 2014In the decade since South Africa finally reversed policy and expanded antiretroviral (ARV) treatment for people with HIV, the population has posted enormous gains in life expectancy, although women have experienced the benefits far more than men, MedPage Today reports. Researchers analyzed demographic data on 52,964 women and 45,688 men that was collected by the Africa Centre for Health and Population Studies in KwaZulu-Natal province between 2000 and 2011. They presented their findings at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.

A total of 6,140 women died during the study, for a mortality rate of 1.85 per person-years. A total of 6,150 men died, for a mortality rate of 2.17 per 100 person-years. Among these deaths, 3,729 of the women’s were related to HIV, for an HIV mortality rate of 1.12 per 100 person years. A total of 3,500 of the men’s deaths were HIV related, for an HIV mortality rate of 1.23 per 100 person years.

Across the board, the longevity of South Africans with HIV who survived childhood rose from about 50 to 60 years old between 2004 and 2011. For men, the average longevity rose from 46 to 55 years old. The average for women elevated from 50 to 64 years old. The longevity gap between the sexes has vacillated over time: In 2001, it was nearly seven years, then dropped to less than four years by 2006, only to rise to more than eight years today.

The investigators found that South African women were 2.5-times more likely to use ARVs than men, which may partly account for the discrepancy in longevity. Seventy percent of the men who died of HIV-related causes had never taken therapy for the virus.

To read the MedPage Today story, click here.

Search: HIV, Conference on Retroviruses and Opportunistic Infections, CROI, South Africa, longevity, Africa Centre for Health and Population Studies.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.